Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Public Health ; 123(7): 490-5, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19615705

RESUMEN

OBJECTIVES: Most comparisons of health in Europe take place at the national level. However, there is increased interest in looking at health data at a sub-national level. This study aimed to establish the availability of health data at a regional level and to develop a methodology for the comparisons of health indicators at a sub-national level. In previous work on indicators at a regional level in the European Union, the authors recommended the development of such indicators. This paper takes into account the expansion of the European Union which took place in 2004. STUDY DESIGN: Observational study using routinely available data. METHODS: Similar to previous projects, a network of country correspondents was used and data were collected on a similar range of topics. In addition, a supplementary list of data was collected from one region of each country. RESULTS: Twenty-three countries out of the 25 member states of the European Union participated in the study. Where available, data were of relatively good quality. Data on mortality were most readily available, but data on important public health topics such as obesity were much more difficult to obtain. CONCLUSIONS: A database and a set of indicators for relevant sub-national areas of countries in the European Union, including new countries, were constructed. Data collection from the new countries was more straightforward due to the requirement for them to adhere to the nomenclature of territorial units for statistics (NUTS) levels. The lack of adherence to NUTS levels in the 'old' countries of the European Union continues to create problems. There remains an urgent need to introduce comprehensive sub-national data collection on important public health topics such as obesity and smoking.


Asunto(s)
Unión Europea , Indicadores de Salud , Regionalización , Recolección de Datos , Demografía , Europa (Continente)/epidemiología , Humanos , Observación
2.
Plant Dis ; 91(4): 462, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30781200

RESUMEN

Xanthomonas axonopodis pv. dieffenbachiae, the causal agent of bacterial blight of aroids (BBA), has been reported in many regions and has been isolated on several host genera (1). During February 2004, in a nursery (Mont Dore) in New Caledonia, suspect symptoms have been observed on anthurium and dieffenbachia plants. A survey carried out on the entire island revealed that X. axonopodis pv. dieffenbachiae was present in 41 of the 89 nurseries inspected. During hot and humid weather, marginal or interveinal water-soaked spots surrounded by chlorotic or necrotic areas were observed, usually followed by a systemic phase (stem rotting and death of the plant). During the cold and dry season, only water-soaked spots were observed. Seventy pure cultures isolated from anthurium and dieffenbachia were gram negative, yellow pigmented, and had a mucoid aspect when grown on rich media. All strains responded positively to the Xcd108 monoclonal antibody (Agdia Inc., Elkhart, IN) raised against X. axonopodis pv. dieffenbachiae using indirect ELISA. A set of 18 strains (isolated from 15 anthurium and 3 dieffenbachia plants located in different sites) were further characterized by molecular and pathogenicity tests. All strains reacted positively using a specific nested PCR assay (1). Pathogenicity tests were performed on 8-month-old plants of Anthurium andreanum 'Carré', Dieffenbachia maculata 'Tropic Marianne', and Syngonium podophyllum 'Robusta' by syringue infiltration of a suspension containing approximately 105 CFU mL-1. Each strain was inoculated onto three young leaves (four inoculation sites per leaf) on two plants. Control plants received sterile Tris buffer solution (10 mM, pH 7.2). Plants were maintained in a growth chamber with day and night temperatures of 30 ± 1°C and 26 ± 1°C, respectively, 95 ± 5% relative humidity, 30 µmol m-2·s-1 light intensity and a photoperiod of 12 h (1). On all plants, all strains caused typical water-soaked symptoms within 10 days, evolving into chlorotic then necrotic areas after 20 to 24 days. Amplified fragment length polymorphism (AFLP) markers revealed three haplotypes among these strains, which suggests that several introduction events may have occurred. These AFLP fingerprints were compared with other Xanthomonas spp. pathovars, including most of X. axonopodis pv. dieffenbachiae strains obtained from international culture collections, and were found to belong to the same genomic group as all the X. axonopodis pv. dieffenbachiae strains pathogenic on anthurium. Importation in New Caledonia of aroids from countries in which X. axonopodis pv. dieffenbachiae is present (Hawaii, French Polynesia, the Netherlands, and Australia) occurred before 2004. The wide distribution of BBA is very likely due to the plant material movements occurring in New Caledonia and suggests that the pathogen may have been present on the territory some years before the first official case. Reference: (1) I. Robene-Soustrade et al. Appl. Environ. Microbiol. 72:1072, 2006.

3.
Rev Epidemiol Sante Publique ; 53(2): 153-65, 2005 Apr.
Artículo en Francés | MEDLINE | ID: mdl-16012374

RESUMEN

OBJECTIVE: Our aim was to describe the living conditions of disabled elderly subjects aged 75 years and more living at home. DESIGN: This study was conducted in 1996-97 in the Alsace region in France and included two parts. First, a sample survey was mailed to 15,600 subjects randomly selected from a pension funds list. This survey provided with a reliable representation of the study population in terms of disabilities using the Colvez classification. In the second part, the most disabled individuals were selected and, among them, 1,259 subjects were visited at home. Their disabilities and living conditions were noted using a predefined set of questions. RESULTS: An estimated 71,000 subjects aged 75 years and more lived at home in the study region. The vast majority were free of significant disability. Help to wash and dress was needed by 6,000 until 1,500 were bedridden or confined to an armchair. Between 4,350 and 5,400 met the criteria for iso-resource grades (IRG) 1 to 3. Disability was associated with age, female gender, cognitive impairment and some social and professional characteristics. Family support was routine in almost every aspect of everyday life including personal hygiene. Professional support was mostly limited to technical interventions. Professional nursing care concerned only the most dependent persons. Nevertheless, needs for help in home and social activities remained high even in the least dependent individuals and were strongly age-dependent. Only 10% of individuals with IRG 1 to 3 complained of inadequate help. More than 80% of the elderly felt comfortable with their living conditions at home and were not thinking of moving from home to an institution for old people. CONCLUSION: The present study confirms the important commitment of family members and their close relationships toward their elderly.


Asunto(s)
Personas con Discapacidad/estadística & datos numéricos , Características de la Residencia , Actividades Cotidianas , Factores de Edad , Anciano , Anciano de 80 o más Años , Cuidadores/estadística & datos numéricos , Trastornos del Conocimiento/epidemiología , Femenino , Francia/epidemiología , Servicios de Atención de Salud a Domicilio/estadística & datos numéricos , Humanos , Entrevistas como Asunto , Masculino , Factores Sexuales , Apoyo Social , Encuestas y Cuestionarios
5.
Fundam Clin Pharmacol ; 9(4): 357-65, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-8566935

RESUMEN

As growth hormone (GH) and insulin-like growth factor type I (IGF-I) have been suggested to be involved in the development of some proliferative ocular disorders, we investigated the eventual antiproliferative properties of a long acting somatostatin analogue, somatuline or BIM23014 (IPSEN Biotech, France), in an original model of experimental proliferative vitreoretinopathy. Two studies were separately done to investigate respective effects of subcutaneously- and intravitreally administered somatuline. Injections of 10(7) human platelets freshly prepared from a unique normal donor were injected into the vitreous, cavity of pigmented rabbits. The first experiment consisted of evaluating vitreoretinal proliferation in 17 eyes from rabbits receiving subcutaneous injections of 25 micrograms/kg of BIM23014, given twice a day, from the day after injection for one month. A group of 14 eyes served as non treated controls. The second experiment was conducted in 33 eyes: 10 received intravitreally 1 microgram of somatuline given once a week for one month, 10 eyes similarly received 5 micrograms/week of somatuline, the remaining 13 eyes serving as controls with intravitreal injections of sterile saline. All animals were examined ophthalmoscopically twice a week for one month in a masked manner, and sacrificed at the end of the experiment for histological and immunohistological analyses. In all but two eyes from the subcutaneously treated group, intravitreal and preretinal membranes formed, five to eight days after platelet injection. Intravitreal proliferation progressively increased, resulting in various degrees of vitreoretinal retraction and retinal detachment.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Octreótido/análogos & derivados , Péptidos Cíclicos , Desprendimiento de Retina/tratamiento farmacológico , Somatostatina/análogos & derivados , Vitreorretinopatía Proliferativa/tratamiento farmacológico , Animales , Plaquetas/citología , Modelos Animales de Enfermedad , Humanos , Inyecciones , Inyecciones Intravenosas , Inyecciones Subcutáneas , Masculino , Octreótido/administración & dosificación , Octreótido/farmacología , Octreótido/uso terapéutico , Conejos , Retina/patología , Desprendimiento de Retina/etiología , Desprendimiento de Retina/patología , Vitreorretinopatía Proliferativa/complicaciones , Vitreorretinopatía Proliferativa/patología , Cuerpo Vítreo
6.
Exp Eye Res ; 59(6): 697-706, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7698262

RESUMEN

An original model of experimental proliferative vitreoretinopathy consisting of an intravitreal injection of 10(7) human platelets and 1 IU of hyaluronidase was developed in pigmented rabbits. One group of 11 eyes served as non-treated controls. Two other groups of 11 eyes each received Ginkgo Biloba extracts which are known free radical scavengers (EGb761, Ipsen, France), given orally in two doses, 50 mg kg-1 day-1 and 100 mg kg-1 day-1 respectively, from the day after the platelet injection to the end of the first month. The fourth group (11 eyes) was intravenously injected with a unique dose of 15000 U kg-1 of superoxide dismutase the day after platelet injection. All animals were ophthalmoscopically examined in a masked fashion twice a week for 1 month and killed at the end of the experiment for histological analysis. Vitreoretinal proliferation was graded according to a six-stage classification. The non-treated eyes showed a high rate of retinal detachment (11/11 eyes), with a mean final score of 3.91 +/- 0.94. Histologic examinations consistently showed retinal retraction by fibrocellular preretinal membranes spreading to both surfaces of the retina as well as preretinal neovascularization. Many cells positively reacted with anti-cytokeratin or anti-vimentin monoclonal antibodies. All three groups of treated eyes showed significantly lower scores of vitreoretinal proliferation at almost each time point of examination. At the end of the study, five retinal detachments were found in the EGb761 group at 50 mg kg-1 day-1 (mean final score 2.45 +/- 1.37), only one in the group receiving 100 mg kg-1 day-1 (mean score 1.64 +/- 1.03), and one in the SOD treated eyes. The lowest mean score found at day 28 was observed in the group receiving SOD (1.36 +/- 1.43), although this group presented during the first 3 weeks with an intense vitreous and sometimes anterior chamber inflammation. Statistical comparison between treatments did not show significant differences at most time points of the study. These results demonstrate that antioxidants may efficiently prevent preretinal proliferation, in clinicopathological entities where free radicals had not yet been shown to play a direct pathogenetic role. They are also among the first attempts for inhibiting preretinal proliferations with non-cytotoxic agents and using a non-ocular route.


Asunto(s)
Depuradores de Radicales Libres/uso terapéutico , Desprendimiento de Retina/prevención & control , Animales , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ginkgo biloba , Masculino , Extractos Vegetales/uso terapéutico , Conejos , Retina/patología , Desprendimiento de Retina/patología , Superóxido Dismutasa , Factores de Tiempo
7.
Nephrol Dial Transplant ; 3(4): 405-11, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3140125

RESUMEN

Using an original technique permitting repeated plasma exchange in the rat, we have tested this therapeutic approach in animals actively immunised with horseradish peroxidase, and in rats with HgCl2-induced autoimmune glomerulonephritis. Plasma exchange effectively removes circulating IgG anti-horseradish peroxidase antibodies from the sera of immunised rats. When applied to the model of HgCl2-induced antiglomerular basement membrane glomerulonephritis in Brown-Norway rats, this technique is also remarkably effective. In these rats, proteinuria is abolished during the plasma exchange treatment period and no circulating antiglomerular basement membrane antibodies can be detected. These antibodies are, however, found in the ultrafiltrates of exchanged rats. Serum IgE, characteristically elevated in HgCl2-treated rats, is also markedly diminished in exchanged rats. Control rats treated with infusions of fresh frozen plasma or with heparin alone did not show any improvement in disease severity. These results suggest that plasma exchange alone can attenuate antiglomerular basement membrane nephritis in HgCl2-treated rats. This observation may be of relevance for the treatment of human antiglomerular-basement membrane-mediated glomerulonephritis.


Asunto(s)
Enfermedades Autoinmunes/terapia , Glomerulonefritis/terapia , Intercambio Plasmático , Animales , Autoanticuerpos/análisis , Enfermedades Autoinmunes/inmunología , Membrana Basal/inmunología , Modelos Animales de Enfermedad , Femenino , Glomerulonefritis/inmunología , Peroxidasa de Rábano Silvestre/inmunología , Glomérulos Renales/inmunología , Masculino , Cloruro de Mercurio/toxicidad , Plasmaféresis , Ratas , Ratas Endogámicas BN
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA